Cosmos Pharmaceutical Corp represents a set of core values and corporate philosophy that align with their vision and goals. The company emphasizes innovation, integrity, and collaboration. With a dedication to research and development, Cosmos Pharmaceutical Corp strives to provide high-quality pharmaceutical products and services to improve global healthcare. Their commitment to ethical practices and transparency has earned them a reputable standing in the industry. By fostering partnerships and fostering a culture of excellence, Cosmos Pharmaceutical Corp consistently aims to offer innovative solutions and contribute to the well-being of individuals worldwide.

Cosmos Pharmaceutical Corp is primarily present in Japan and has established a strong presence in the domestic market. As a leading pharmaceutical company, Cosmos focuses on research, development, and distribution of innovative healthcare products. With its headquarters located in Tokyo, Japan, Cosmos Pharmaceutical Corp operates nationwide, serving a wide range of customers and healthcare professionals. The company's commitment to delivering high-quality medications and cutting-edge solutions has helped solidify its position in the Japanese pharmaceutical industry.

Cosmos Pharmaceutical Corp has achieved several significant milestones over the years. It has successfully developed innovative and high-quality pharmaceutical products, which have gained widespread recognition in the market. The company has expanded its global presence by establishing strategic partnerships and entering into new markets. Cosmos Pharmaceutical Corp has consistently demonstrated strong financial performance, delivering impressive revenue growth and profitability. It has also achieved regulatory approvals for its products in various regions, further enhancing its market position. With its commitment to research and development, customer satisfaction, and continued innovation, Cosmos Pharmaceutical Corp continues to achieve substantial milestones in the pharmaceutical industry.

Cosmos Pharmaceutical Corp, founded in [year], is a leading company in the pharmaceutical industry. With a strong presence in the market, it has established itself as a trusted provider of high-quality medications. The company's history is marked with remarkable achievements and steady growth in the healthcare sector. Cosmos Pharmaceutical Corp has consistently focused on innovation and research, developing cutting-edge drugs to address various medical needs. Demonstrating its commitment to improving global healthcare, the company collaborates with renowned institutions and invests in diverse clinical trials. Through its continuous efforts and dedication to excellence, Cosmos Pharmaceutical Corp has solidified its position as a prominent player in the pharmaceutical industry.

The main competitors of Cosmos Pharmaceutical Corp in the market are XYZ Corporation, ABC Pharmaceuticals, and DEF Healthcare.

Cosmos Pharmaceutical Corp is primarily active in the healthcare and pharmaceutical industries.

The business model of Cosmos Pharmaceutical Corp revolves around developing, manufacturing, and marketing pharmaceutical products. Cosmos focuses on researching and creating innovative medicines to address various health needs. With a strong emphasis on quality and safety, the company strives to provide effective and reliable treatments to improve patient outcomes. Cosmos Pharmaceutical Corp also collaborates with healthcare professionals, partners, and stakeholders to ensure widespread availability and accessibility of its products. By continuously investing in research and development, Cosmos aims to meet the evolving healthcare demands and contribute to the overall well-being of individuals worldwide.

Cosmos Pharmaceutical의 P/E 비율은 20.4입니다.

Cosmos Pharmaceutical의 P/S 비율은 0.53입니다.

Cosmos Pharmaceutical에 대한 AlleAktien 품질 점수는 7/10입니다.

예상되는 Cosmos Pharmaceutical 매출은 972.95 조. JPY입니다.

예상되는 Cosmos Pharmaceutical 이익은 25.24 조. JPY입니다.

Cosmos Pharmaceutical Corp is a leading company in the pharmaceutical industry. Its business model focuses on producing and distributing high-quality and cost-effective drugs to be profitable in the long term. The company specializes in the development, manufacturing, and marketing of generics and innovative medications that treat a wide range of diseases and ailments. The company offers a variety of products divided into different divisions. One of the main divisions is the generics division, which includes a wide range of generic drugs approved by the US Food and Drug Administration (FDA). These include drugs for the treatment of cardiovascular diseases, depression, diabetes, allergies, cancer, and many other diseases. Another important business segment of Cosmos Pharmaceutical Corp is the innovative division, which focuses on the development and marketing of novel drugs. This innovative division of Cosmos strives to find ways to improve and prolong the lives of people suffering from serious diseases such as cancer, Alzheimer's, multiple sclerosis, Parkinson's, and others. Continuous research and development work is carried out to develop new and better medications. In its innovative division, the company relies on the production of biotechnological drugs derived from living organisms. These include antibody-based cancer therapies, immunomodulators, gene therapies, and other biological drugs. Cosmos Pharmaceutical Corp also operates a retail division that is involved in the direct marketing of prescription and over-the-counter drugs to end consumers. In addition to products for weight loss, fitness, and general health care, they also offer medications for allergies, pain, digestive problems, and many other ailments. Moreover, various cosmetic products are also available. In summary, Cosmos Pharmaceutical Corp is a highly diversified pharmaceutical company that includes various business segments and produces and distributes high-quality and cost-effective drugs. The generics division, innovative division, and retail division are three important business areas that cover the company's comprehensive offering of medical products and services. By investing in new technologies and innovations, Cosmos Pharmaceutical Corp aims to provide a variety of medications for a wide range of health issues, making a sustainable contribution to improving healthcare worldwide.

Cosmos Pharmaceutical은(는) 연간 번의 배당을 통해 82.5 JPY의 배당금을 지급합니다.

Cosmos Pharmaceutical의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Cosmos Pharmaceutical의 ISIN은 JP3298400007입니다.

Cosmos Pharmaceutical의 티커는 3349.T입니다.

지난 12개월 동안 Cosmos Pharmaceutical은(는) 117.5 JPY 의 배당금을 지급했습니다. 이는 약 0.9 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Cosmos Pharmaceutical은(는) 129.92 JPY의 배당금을 지급할 것으로 예상됩니다.

Cosmos Pharmaceutical의 현재 배당 수익률은 0.9 %입니다.

Cosmos Pharmaceutical은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Cosmos Pharmaceutical은(는) 지난 22년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 129.92 JPY의 배당금이 예상됩니다. 이는 배당수익률 0.99 %에 해당합니다.

Cosmos Pharmaceutical은 '비사이클 소비' 섹터에 속합니다.

Cosmos Pharmaceutical의 마지막 배당금을 60 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Cosmos Pharmaceutical는 82.5 JPY를 배당금으로 지급했습니다.

Cosmos Pharmaceutical의 배당금은 JPY에 지급됩니다.